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The purpose of this narrative year in review of clinical studies was to highlight a few publications related
to obesity and weight loss, physical activity, and synovitis as well as disease modifying interventions that
were published between September 2010 and September 2011. This year clinical research highlighted the
extent to which obesity and osteoarthritis (OA) are impacting quality of life among adults in the United
States and that reducing excessive body weight or becoming more physically active may be beneﬁcial. In
addition to weight loss and physical activity and synovitis, research over the past year has highlighted
the diverse methods being pursued for structural modiﬁcation interventions. In addition to chondroitin
sulfate there were interesting preliminary ﬁndings that meniscal implants and joint distractions may
modify OA progression.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA), one of the leading causes of physical
disability1,2, is a complex disease characterized by structural
changes and an illness deﬁned by patient-reported symptoms3.
Clinically, OA research continues to strive for a better understanding
of risk factors for structural OA progression and how to ameliorate
these changes as well as optimize symptom-modifying interven-
tions. With a growing obesity epidemic there is a need for us to
understand howpotential comorbidities (e.g., obesity) inﬂuence OA
progression (structural or symptomatic) and interact with OA to
inﬂuence physical disability. Furthermore, the obesity epidemic has
prompted numerous organizations to recommend that individuals
become more physically active4 and lose excessive body weight5;
therefore, it is important to understand the inﬂuence of weight loss
and physical activity onOA incidence and progression. Over the past
year, new evidence has emerged to suggest that weight loss or
moderate recreational physical activity may be beneﬁcial6e9.
In addition to weight loss and physical activity, research over
the past year has highlighted the diverse methods being pursued
for structure modifying interventions. In addition to chondroitin
sulfate10 there were interesting preliminary ﬁndings that meniscalT.E. McAlindon, Tufts Medical
02111, USA. Tel: 1-617-636-
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s Research Society International. Pimplants11 and joint distractions12 may modify OA progression
(structural and symptomatic). The purpose of this narrative review
was not to be a comprehensive review of the literature but rather
highlight a few publications related to obesity and weight loss,
physical activity, and synovitis as well as disease modifying inter-
ventions that were published between September 2010 and
September 2011.
Obesity and weight loss
Obesity and OA are among the most common chronic conditions
afﬂicting older adults but few studies have evaluated quality-of-life
beneﬁts of obesity prevention. To address this gap, Losina et al13
estimated the loss of quality-adjusted life-years (QALY) due to
obesity and knee OA and the potential beneﬁts of reducing the
prevalence of obesity. They applied sophisticated computer-based,
state-transition, Monte Carlo simulation modeling to the United
States census data and obesity data to estimate QALY lost due to OA,
obesity, or both. Compared to nonobese individuals with no knee OA
they found that the estimated loss per-person QALY ranged from 1.9
QALY in nonobese individuals with knee OA to 3.5 QALY for indi-
viduals affected by both conditions. This represents a total of 86
million QALY lost due to obesity, knee OA, or both. Furthermore, this
represents 10e25%of the remainingQALYof individuals 50e84 years
of age. Hispanic and black women had disproportionately greater
QALY losses compared to males and other races/ethnicities.
Reversing the obesity prevalence of the United States to that of
10 years ago could avert over 111,000 total knee replacements andublished by Elsevier Ltd. All rights reserved.
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between 50 and 84 years of age.
This study provides additional support to treatment guide-
lines5,14,15 that advise clinicians to recommend that OA patients
should reduce excessive body weight even though it is unclear how
efﬁcacious this may be for managing OA. Biomechanical studies are
providing further support for recommending weight loss by
determining the mechanisms and potential beneﬁts of weight loss.
Messier et al8 conducted a secondary analysis of the Arthritis, Diet,
and Activity Promotion Trial (ADAPT) to evaluate the effects of high
weight loss on knee loads during walking in individuals with knee
OA. The secondary analysis included 76 sedentary participants that
performed gait analysis at baseline and 18 months. The cohort was
divided into high (>5% weight loss), low (<5% weight loss), and no
(0% or weight gain) weight loss. The analyses revealed that high
weight loss reduces knee joint compressive loads during walking
primarily due to lower hamstring forces.
While Messier et al8 provide evidence of local biomechanical
changes associatedwith highweight loss it remains unclearwhether
there are concurrent systemic changes associated with obesity and
weight loss that are relevant to OA. Richette et al9 evaluated 140
patients undergoing gastric surgery and screened them for symp-
tomatic knee OA. They identiﬁed 44 patients (mean age¼ 44, body
mass index¼ 50.7 kg/m2) and collected clinical data and blood
samples before and 6 months after surgery. The gastric surgery led
to a decrease in body weight (approximately 20%) and knee pain
(approximately 50% on visual analog scale), as well as improvement
on all WOMAC subscales. Biochemically, they found decreased
insulin, insulin resistance, total cholesterol, leptin, interleukin-6, and
high-sensitivity C-reactive protein among several other parameters
that reﬂected the systemic nature of obesity in patients with OA.
Joint biomarkers were also different after surgery compared to pre-
surgery including an increase of serum N-terminal propeptide of
type IIA collagen (PIIANP; biomarker of type II collagen synthesis)
and a reduction of serum cartilage oligomericmatrix protein (COMP;
biomarkers of cartilage degradation).
Overall, these three studies demonstrate that weight loss, at
least large amounts of weight loss (10e20% bodyweight), should be
an important part of our treatment plan for patients with OA and
obesity8,9,13. The studies demonstrate that substantial weight loss
may reduce knee loading, improve knee OA symptoms, as well as
promote positive changes in systemic biomarkers of inﬂammation,
metabolism, and OA8,9. Weight loss may be achieved through
gastric surgery, diet, physical activity, or a combination of these
approaches.
Physical activity
To reduce the negative effects of obesity many organizations
advocate increased physical activity for all ages4. Furthermore,
exercising is advocated in recent OA treatment guidelines5,14,15.
Unfortunately, the inﬂuence of different types of activities (e.g.,
cycling, jogging, soccer) and different levels of participation (elite
sports, recreational physical activity) remains a vexing issue in
clinical practice because there is a gray zone between low-force,
low-repetition activities (e.g., recreational walking) and high-
load, high-repetition sport participation that may also have
a high risk for joint trauma (e.g., elite-level soccer). Urquhart et al6
conducted a systematic review (up through November 2008) to
assess the relationship between physical activity and individual
joint structures at the knee. They identiﬁed 28 eligible studies
including 22 radiological studies (14 longitudinal) and six magnetic
resonance (MR) imaging studies (three longitudinal). The studies
included various types (e.g., soccer, running) and levels (e.g., elite,
recreational) of physical activity, therefore, they could not pool theresults for a meta-analysis. Instead Urquhart et al performed a best
evidence synthesis and found strong evidence (multiple high-
quality cohort studies) for a positive relationship between phys-
ical activity and osteophytes but no relationship to joint space
narrowing. Furthermore, they found an inverse relationship
between physical activity and cartilage defects on MR imaging.
There was limited evidence for an association between physical
activity and cartilage volume.
While Urquhart et al6 looked at general physical activity there has
been evidence to suggest that individuals with a history of sport
participation in certain sports (e.g., soccer), particular elite level
sports with a high risk for injury, have an increased risk for OA16. It is
important to disentangle the various risk factors that may inﬂuence
the effect of physical activity on joints (e.g., type of activity, level of
competition, joint trauma, cumulative exposure to joint loads,
participant age). A recent paper by Michaëlsson et al7 provides
additional insight into the importance of level of competition and
cumulative exposure to joint loading. They evaluated whether level
of physical activity is associated with severe hip or knee OA among
53,983 competitors in a 90-km ski race (1989e1998), of whom
a majority were men. These participants were followed up using
a national patient register that tracked hip or knee arthroplasty
and high tibial osteotomies (mean follow-up¼ 10 years; range¼
0e16 years). The authors accounted for the competitors’ level of
activity by assessing the number of times a competitor participated
in the race as well as their ﬁnishing times (relative to the best
performance). There were 356 cases of hip OA and 227 cases of
knee OA. The cumulative proportion of competitors with OA
increased in a dose-dependent relationship based on the number
of times an individual participated in the races and their ﬁnishing
times. Overall, there was a 9% increase in the rate of hip or knee OA
per completed race; even when controlling for comorbidities and
a history of joint injury. They concluded that intensive physical
activity or sport participation that is required to compete inmultiple
long-distance skiing races and fast speeds may be an important risk
factor for OA.
Based on these two studies, there may be evidence that most
individuals with a history of physical activity are not at a greater
risk for knee OA and are likely to receive beneﬁts associated with
reducing other comorbidities (e.g., metabolic syndrome) towarrant
promoting physical activity. It is important to note that high-level
competitors in sports like long-distance skiing may reach
a threshold sufﬁcient to increase the risk of OA. More research is
needed to deﬁne this threshold and evaluate how body weight/
impact forces, number of repetitions per exposure, recovery time,
frequency of exposures, cumulative exposure over time, and
structural integrity of the joint inﬂuence the threshold.
Synovitis and inﬂammation
During recent years there has been a resurgence of interest in
the contribution of inﬂammation in the structural progression of
OA. Studies have shown a high prevalence of synovial inﬂammation
in osteoarthritic knees17, a relationship to knee pain18e20, and to
structural progression21. However, there has been uncertainty
about the optimal noninvasive method to evaluate synovitis in
knee OA. The recent publication by Krasnokutsky et al is elegant
and informative in evaluating the relationships of quantitative and
semiquantitative assessments of synovial using radiography and
dynamic 3 T MR imaging with and without contrast enhance-
ment22. This study enrolled 58 individuals with knee OA for stan-
dardized ﬁxed-ﬂexion knee radiography and MR imaging. They
used image analysis tools to perform manual segmentation and
measurements of synovial in the entire knee joint and evaluated
signal and enhancement patterns in the infrapatellar fat pad,
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of the joint effusion. Two radiologists also performed semi-
quantitative scoring of synovitis using the Boston Leeds Osteoar-
thritis Knee Score (BLOKS) system23.
They evaluated the reproducibility of these different techniques
and measurements approaches, and analyzed the relationships
between them using multiple regression modeling. The techniques
were highly reproducible and there were strong associations of the
quantitative synovial volume measurement with radiographic
measures of knee OA severity and with bone marrow lesion
volume. In analyses of semiquantitative assessments, they found
relationships of infrapatellar synovitis and effusion with synovial
volume. These relationships appeared stronger in the contrast-
enhanced images, indicating that this intervention improves
measurement of synovial proliferation. The authors inferred from
widespread associations among these diverse pathological mani-
festations, including the relationship between synovial volume and
bonemarrow lesions, that OA is a disease of the whole joint and the
synovitis is characteristic of advancing knee OA severity.
Structural modiﬁcation
There have been anumberof further studies inpursuit of effective
structure-modiﬁcation interventions for OA.Wildi et al reported the
results of a randomized, double-blind, placebo-controlled clinical
trial of chondroitin sulfate, 800 mg daily, administered for
6 months10. This was an investigator-initiated study, supported by
a grant from the manufacturer. They measured cartilage volume,
bone marrow lesions, and synovial thickness at baseline, 6, and
12 months, using noncontrast enhanced MR imaging. As a pilot
study, the sample size was small (69 participants randomized) and
tested numerous cartilage regions of interest. They found that the
chondroitin sulfate group exhibited signiﬁcantly less cartilage
volume loss for the global, lateral compartment, and tibial plateau
regions of interest. However, there were no signiﬁcant differences
between the treatment groups for clinical outcomes such as knee
pain. While one possible interpretation of this result is that an
intervention that beneﬁts cartilage loss may require a greater than
1-year duration for its effect to translate into clinically important
beneﬁt, it also raises questions about the timing and utility of
structure modiﬁcation.
There have during the last year, however, been two studies of
more intensive interventions that provide proof of concept infor-
mation to structuremodiﬁcation and symptom change. In theﬁrst of
these reports, Zaffagnini et al11 presented the 10-year outcomes of 33
menwho received a collagenousmeniscus implant as a treatment for
meniscal injury. The patients chose whether to receive medial
collagen meniscus implant or partial medial meniscectomy, so the
study was not randomized. They were evaluated with a compre-
hensive clinical assessment, bilateral weight-bearing knee radio-
graphs, and knee MR images 5 and 10 years after the procedures.
There were noticeable and signiﬁcant between group differences in
respect to knee pain, quality of life, and also the extent of medial
compartment joint space narrowing in the index knee compared to
the patient’s contralateral knee (as a control). Although this small
study has some limitations, it indicates that structure modiﬁcation,
albeit a surgical intervention, can translate into meaningful clinical
beneﬁt in the long term.
Tissue structure modiﬁcation in knee OA can also be accom-
plished by joint distraction. In this fascinating report, Intema et al12
described outcomes among 20 patients aged over 60 years who had
tibiofemoral OA. Surgical distraction to greater than 5 mm joint
space width was applied orthopedically for 2 months. Outcomes
measured at 1 year included knee pain, radiographic joint
space width, cartilage metrics using MR imaging, and turnoverbiomarkers. The results of this study are remarkable in showing an
increase in structural parameters (rather than a slowing of loss).
They found an increase in radiographic joint space width and an
increase in cartilage thickness along with decrease in the area of
denuded bone. Knee pain also decreased substantially. This study
not only showed that joint distraction can induce tissue structure
modiﬁcation in knee OA, but also provided proof of concept that
repair of cartilage is possible and that this can translate into real in
clinical beneﬁt.
Author contributions
Timothy McAlindon contributed to the conception and design,
collection and assembly of data, analysis and interpretation of data,
drafting/revisions of article, as well as ﬁnal approval of the article.
Jeffrey Driban contributed to the conception and design,
collection and assembly of data, analysis and interpretation of data,
drafting/revisions of article, as well as ﬁnal approval of the article.
Grace Lo contributed to the conception and design, collection
and assembly of data, analysis and interpretation of data, drafting/
revisions of article, as well as ﬁnal approval of the article.
Role of funding source
This work was supported in part by the Houston VA HSR&D Center
of Excellence (HFP90-020). The views expressed in this article are
those of the author(s) and do not necessarily represent the views of
the Department of Veterans Affairs.
Competing interest statement
Timothy McAlindon has received payments in respect of consul-
tative services from Flexion, and Allergan, and received a speaker
fee from IBSA.
References
1. Guccione AA, Felson DT, Anderson JJ, Anthony JM, Zhang Y,
Wilson PW, et al. The effects of speciﬁc medical conditions on
the functional limitations of elders in the Framingham Study.
Am J Public Health 1994;84:351e8.
2. Michaud CM, McKenna MT, Begg S, Tomijima N, Majmudar M,
Bulzacchelli MT, et al. The burden of disease and injury in the
United States 1996. Popul Health Metr 2006;4:11.
3. Lane NE, Brandt K, Hawker G, Peeva E, Schreyer E, Tsuji W,
et al. OARSI-FDA initiative: deﬁning the disease state of oste-
oarthritis. Osteoarthritis Cartilage 2011;19:478e82.
4. Physical Activity Guidelines Advisory Committee Report.
http://www.health.gov/paguidelines/Report/Default.aspx.
5. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD,
Arden N, et al. OARSI recommendations for the management of
hip and knee osteoarthritis, Part II: OARSI evidence-based,
expert consensus guidelines. Osteoarthritis Cartilage 2008;
16:137e62.
6. Urquhart DM, Tobing JF, Hanna FS, Berry P, Wluka AE, Ding C,
et al. What is the effect of physical activity on the knee joint?:
A systematic review. Med Sci Sports Exerc 2011;43:432e42.
7. Michaelsson K, Byberg L, Ahlbom A, Melhus H, Farahmand BY.
Risk of severe knee and hip osteoarthritis in relation to level of
physical exercise: a prospective cohort study of long-distance
skiers in Sweden. PLoS One 2011;6:e18339.
8. Messier SP, Legault C, Loeser RF, Van Arsdale SJ, Davis C,
Ettinger WH, et al. Does high weight loss in older adults with
knee osteoarthritis affect bone-on-bone joint loads and muscle
forces during walking? Osteoarthritis Cartilage 2011;19:
272e80.
T.E. McAlindon et al. / Osteoarthritis and Cartilage 20 (2012) 197e2002009. Richette P, Poitou C, Garnero P, Vicaut E, Bouillot JL, Lacorte JM,
et al. Beneﬁts of massive weight loss on symptoms, systemic
inﬂammation and cartilage turnover in obese patients with
knee osteoarthritis. Ann Rheum Dis 2011;70:139e44.
10. Wildi LM, Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L,
Morin F, et al. Chondroitin sulphate reduces both cartilage
volume loss and bone marrow lesions in knee osteoarthritis
patients starting as early as 6months after initiation of therapy:
a randomised, double-blind, placebo-controlled pilot study
using MRI. Ann Rheum Dis 2011;70:982e9.
11. Zaffagnini S, Marcheggiani Muccioli GM, Lopomo N, Bruni D,
Giordano G, Ravazzolo G, et al. Prospective long-term
outcomes of the medial collagen meniscus implant versus
partial medial meniscectomy: a minimum 10-year follow-up
study. Am J Sports Med 2011;39:977e85.
12. Intema F, Van Roermund PM, Marijnissen AC, Cotofana S,
Eckstein F, Castelein RM, et al. Tissue structure modiﬁcation in
knee osteoarthritis by use of joint distraction: an open 1-year
pilot study. Ann Rheum Dis 2011;70:1441e6.
13. Losina E, Walensky RP, Reichmann WM, Holt HL, Gerlovin H,
Solomon DH, et al. Impact of obesity and knee osteoarthritis on
morbidity and mortality in older Americans. Ann Intern Med
2011;154:217e26.
14. The care and management of osteoarthritis in adults. http://
www.nice.org.uk/nicemedia/live/11926/39557/39557.pdf.
15. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW,
Dieppe P, et al. EULAR recommendations 2003: an evidence
based approach to the management of knee osteoarthritis:
report of a Task Force of the Standing Committee for Inter-
national Clinical Studies Including Therapeutic Trials (ESCISIT).
Ann Rheum Dis 2003;62:1145e55.
16. Roos H, Lindberg H, Gardsell P, Lohmander LS, Wingstrand H.
The prevalence of gonarthrosis and its relation tomeniscectomy in former soccer players. Am J Sports Med
1994;22:219e22.
17. Pearle AD, Scanzello CR, George S, Mandl LA, Dicarlo EF,
Peterson M, et al. Elevated high-sensitivity C-reactive protein
levels are associatedwith local inﬂammatoryﬁndings inpatients
with osteoarthritis. Osteoarthritis Cartilage 2007;15:516e23.
18. Torres L, Dunlop DD, Peterfy C, Guermazi A, Prasad P,
Hayes KW, et al. The relationship between speciﬁc tissue
lesions and pain severity in persons with knee osteoarthritis.
Osteoarthritis Cartilage 2006;14:1033e40.
19. Zhang Y, Nevitt M, Niu J, Lewis C, Torner J, Guermazi A, et al.
Fluctuation of knee pain and changes in bone marrow lesions,
effusions and synovitis on MRI: the most study. Arthritis
Rheum 2010.
20. Yusuf E, Kortekaas MC, Watt I, Huizinga TW, Kloppenburg M.
Do knee abnormalities visualised on MRI explain knee pain in
knee osteoarthritis? A systematic review. Ann Rheum Dis
2011;70:60e7.
21. Roemer FW, Guermazi A, Felson DT, Niu J, Nevitt MC,
Crema MD, et al. Presence of MRI-detected joint effusion and
synovitis increases the risk of cartilage loss in knees without
osteoarthritis at 30-month follow-up: the MOST study. Ann
Rheum Dis 2011;70:1804e9.
22. Krasnokutsky S, Belitskaya-Levy I, Bencardino J, Samuels J,
Attur M, Regatte R, et al. Quantitative magnetic resonance
imaging evidence of synovial proliferation is associated with
radiographic severity of knee osteoarthritis. Arthritis Rheum
2011;63:2983e91.
23. Hunter DJ, Lo GH, Gale D, Grainger AJ, Guermazi A, ConaghanPG.
The reliability of a new scoring system for knee osteoarthritis
MRI and the validity of bone marrow lesion assessment: BLOKS
(Boston Leeds Osteoarthritis Knee Score). Ann Rheum Dis
2008;67:206e11.
